https://www.businesswire.com/news/home/20220808005231/en/Karuna-Therapeutics-Reports-Second-Quarter-2022-Financial-Results-and-Provides-General-Business-Updates
Karuna Therapeutics Reports Second Quarter 2022 Financial Results and Provides General Business...
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living ...
karuna therapeuticssecond quarter2022 financial
https://www.businesswire.com/news/home/20231116001299/en/PureTech-Founded-Entity-Karuna-Therapeutics-Announces-Positive-Results-from-Phase-1b-Ambulatory-Blood-Pressure-Monitoring-Trial-of-KarXT-in-Schizophrenia
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory...
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Ph 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
karuna therapeutics
https://companiesmarketcap.com/karuna-therapeutics/cost-to-borrow/
Karuna Therapeutics (KRTX) - Cost to borrow
List of the companies with highest cost to borrow on Interactive Brokers. The cost to borrow is in annualized percents.
karuna therapeuticskrtxcostborrow
https://www.benzinga.com/analyst-ratings/23/07/33217681/the-latest-analyst-ratings-for-karuna-therapeutics
The Latest Analyst Ratings for Karuna Therapeutics - Benzinga
the latestanalyst ratingskaruna therapeuticsbenzinga
https://www.businesswire.com/news/home/20230522005093/en/Karuna-Therapeutics-to-Present-Data-from-the-EMERGENT-Program-Evaluating-KarXT-in-Schizophrenia-at-the-American-Society-of-Clinical-Psychopharmacology-Annual-Meeting
Karuna Therapeutics to Present Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at...
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living ...
https://www.biospace.com/puretech-founded-entity-karuna-therapeutics-to-be-acquired-by-bristol-myers-squibb-for-14-billion
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion...
Dec 22, 2023 - PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") noted today that its Founded Entity, Karuna Therapeutics, Inc., and (Nasdaq: KRTX)...
https://www.benzinga.com/news/earnings/22/08/28400912/dow-jumps-over-150-points-karuna-therapeutics-shares-spike-higher
Dow Jumps Over 150 Points; Karuna Therapeutics Shares Spike Higher - Bed Bath & Beyond (NYSE:BBBY)...
Aug 8, 2022 - U.S. stocks traded higher this morning, following the release of strong jobs data on Friday.
https://www.biospace.com/karuna-therapeutics-to-announce-third-quarter-2023-financial-results-and-provide-general-business-update-on-thursday-november-2-2023
Karuna Therapeutics to Announce Third Quarter 2023 Financial Results and Provide General Business...
Oct 20, 2023 - Karuna Therapeutics, Inc. (NASDAQ: KRTX) today announced that it will host a live conference call and webcast on Thursday, November 2, 2023 at 8:00 a.m. ET to...